Sound wave therapy plus chemo for advanced pancreatic cancer
Treatments studied
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial tests a new treatment that uses sound waves to help chemotherapy reach pancreatic tumors more effectively. It is for people with locally advanced pancreatic cancer that cannot be removed with surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have locally advanced pancreatic cancer that cannot be removed with surgery yet.
- Your doctor says you can safely have the chemotherapy combination mFOLFIRINOX.
- You have not had any prior chemotherapy, surgery, or radiation for your pancreatic cancer.
- You may have had a procedure to bypass a blocked bile duct or a stent placed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether combining targeted radiation with an at-home “tumor treating fields” device can better control locally advanced pancreatic cancer. It may help by attacking cancer cells in more than one way after prior chemotherapy.
This trial tests a new approach that uses sound waves (sonoporation) to help chemotherapy drugs get into liver tumors. It is for people with pancreatic cancer that has spread to the liver and who have already tried one type of chemotherapy.
This trial tests a new device that uses sound waves (histotripsy) to break apart pancreatic tumors without surgery. It is for people with advanced pancreatic cancer that cannot be removed and who have already had chemotherapy. The goal is to see if this treatment can help control the tumor.
This trial tests combining endoscopic ultrasound-guided radiofrequency ablation with FOLFIRINOX chemotherapy for people with advanced pancreatic cancer that hasn't spread to other organs. It aims to see if this approach is safe and effective.
This trial tests whether giving a strong chemotherapy combination (mFOLFIRINOX) together with radiation therapy can help people with advanced pancreatic cancer who have normal CA19-9 levels. It aims to see if this approach is more effective for this specific group of patients.
This trial tests a combination of chemotherapy (mFOLFIRINOX) and radiation therapy for people with advanced pancreatic cancer that has stopped responding to chemotherapy and whose CA19-9 tumor marker levels are normal. The goal is to see if this approach can help when standard treatments are no longer working.
Hear when a new Locally Advanced Pancreatic Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.